We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$1.64B
AUM Growth
+$23.5M
Cap. Flow
-$31.1M
Cap. Flow %
-1.9%
Top 10 Hldgs %
31.5%
Holding
630
New
91
Increased
163
Reduced
168
Closed
91

Top Buys

Rank Stock Value
1
IYR icon
iShares US Real Estate ETF
IYR
+$56.7M
2
BND icon
Vanguard Total Bond Market
BND
+$56M
3
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$16.8M
4
GOVT icon
iShares US Treasury Bond ETF
GOVT
+$11.4M
5
MBB icon
iShares MBS ETF
MBB
+$11.3M

Top Sells

Rank Stock Value
1
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$58.5M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$31.9M
3
IAU icon
iShares Gold Trust
IAU
+$29.4M
4
GLD icon
SPDR Gold Trust
GLD
+$22.9M
5
TFI icon
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
+$8.19M

Sector Composition

Rank Sector Weight
1 Technology 14.03%
2 Healthcare 7.09%
3 Financials 4.96%
4 Communication Services 4.91%
5 Industrials 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPST icon
376
JPMorgan Ultra-Short Income ETF
JPST
$40B
$350K 0.02%
+6,955
New +$350K
GII icon
377
State Street SPDR S&P Global Infrastructure ETF
GII
$936M
$348K 0.02%
6,550
– –
BIIB icon
378
Biogen
BIIB
$29.6B
$345K 0.02%
1,474
+55
+4% +$12.7K
DMC
379
Del Monte Corp
DMC
$1.35B
$345K 0.02%
12,800
-2,500
-16% -$68.2K
TMO icon
380
Thermo Fisher Scientific
TMO
$213B
$344K 0.02%
1,171
-44
-4% -$12.1K
BMRN icon
381
BioMarin Pharmaceuticals
BMRN
$11.4B
$343K 0.02%
4,000
– –
FBP icon
382
First Bancorp
FBP
$4.4B
$343K 0.02%
+31,100
New +$334K
MOFG
383
DELISTED
MidWestOne Financial Group
MOFG
$341K 0.02%
12,201
-300
-2% -$8.49K
WBA
384
DELISTED
Walgreens Boots Alliance
WBA
$340K 0.02%
6,216
+1,694
+37% +$90.1K
HDV
385
iShares Core High Dividend ETF
HDV
$14.3B
$337K 0.02%
17,850
– –
LEXEA
386
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
$335K 0.02%
+7,000
New +$309K
RPD icon
387
Rapid7
RPD
$639M
$333K 0.02%
+5,750
New +$303K
SCS
388
DELISTED
Steelcase
SCS
$332K 0.02%
+19,400
New +$323K
GPK icon
389
Graphic Packaging
GPK
$3.25B
$331K 0.02%
23,700
– –
VNQI icon
390
Vanguard Global ex-US Real Estate ETF
VNQI
$3.44B
$331K 0.02%
5,614
-310
-5% -$18.1K
MATX icon
391
Matsons
MATX
$6.46B
$330K 0.02%
8,500
-4,300
-34% -$163K
MANT
392
DELISTED
Mantech International Corp
MANT
$329K 0.02%
+5,000
New +$304K
TDS icon
393
Telephone and Data Systems
TDS
$3.83B
$328K 0.02%
10,800
-9,800
-48% -$306K
SHOO icon
394
Steven Madden
SHOO
$3.08B
$326K 0.02%
9,600
-4,200
-30% -$138K
MRKR icon
395
Marker Therapeutics
MRKR
$21.2M
$325K 0.02%
4,100
+1,000
+32% +$59.4K
SAH icon
396
Sonic Automotive
SAH
$3.13B
$325K 0.02%
13,900
-8,400
-38% -$162K
JCAP
397
DELISTED
Jernigan Capital, Inc.
JCAP
$324K 0.02%
15,800
+1,900
+14% +$40K
AVT icon
398
Avnet
AVT
$7.38B
$321K 0.02%
7,100
+500
+8% +$22.3K
XBI icon
399
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$321K 0.02%
3,661
– –
BRK.A icon
400
Berkshire Hathaway Class A
BRK.A
$1.06T
$318K 0.02%
1
– –
14 15
16
17 18

Similar funds

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
NHC
Nicholas Hoffman & Company Atlanta, Georgia $4.33B AUM 18.98% 1-Year Est. Return
EQF
Evergreen Quality Fund Grand Cayman, Cayman Islands $4.37B AUM 119.42% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return

Bailard's Q2 2019 Portfolio in Review

As of Q2 2019, Bailard held 630 positions worth $1.64B, up 1.5% from $1.61B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bailard's Q2 2019 filing shows 91 new, 163 increased, 168 reduced and 91 closed positions. Its largest new stake was Vanguard Total Bond Market: 687,016 shares worth $57.1M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $58.5M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q2 2019 buy was Vanguard Total Bond Market: 687,016 shares worth $57.1M.
  • Bailard added most to iShares US Real Estate ETF in Q2 2019, an estimated $56.7M increase.
  • Bailard's biggest Q2 2019 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $58.5M.
  • Bailard fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $5.65M.
  • Bailard's ten largest holdings make up 32% of its $1.64B portfolio in Q2 2019.
  • Bailard opened 91 new positions and closed 91 in Q2 2019.
  • Bailard's portfolio value rose 1.5% quarter-over-quarter to $1.64B.

Based on Bailard's 13F filing for Q2 2019, filed 26 Jul 2019.